Report overview
This report contains market size and forecasts of Prostate Cancer Diagnostics Solution in Global, including the following market information:
Global Prostate Cancer Diagnostics Solution Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Diagnostics Solution market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tumor Biomarker Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnostics Solution include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnostics Solution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics Solution Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Diagnostics Solution Market Segment Percentages, by Type, 2021 (%)
Tumor Biomarker Tests
Imaging
Biopsy
Other
Global Prostate Cancer Diagnostics Solution Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Diagnostics Solution Market Segment Percentages, by Application, 2021 (%)
Age Below 55
Age 55-75
Age Above 75
Global Prostate Cancer Diagnostics Solution Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Cancer Diagnostics Solution Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics Solution revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics Solution revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
